We’re buying the dip in a health and life sciences stock that has gone down enough
We're buying 20 more shares of Danaher at roughly $180 each. Following Thursday's trade, Jim Cramer's Charitable Trust will own ...
Tag: Sciences
Record funding propels Denver-Boulder’s life sciences market
This story is a component of CNBC's quarterly Cities of Success series, which explores cities which have transformed into business ...
U.S. loses HIV patent suit against Gilead Sciences over PrEP
The emblem of Gilead Sciences pharmaceutical company is seen in Oceanside, California, April 29, 2020.Mike Blake | ReutersA Delaware federal ...
